Marisa Pautasso

853 total citations
35 papers, 584 citations indexed

About

Marisa Pautasso is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Marisa Pautasso has authored 35 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Genetics and 7 papers in Immunology. Recurrent topics in Marisa Pautasso's work include Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Marisa Pautasso is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Marisa Pautasso collaborates with scholars based in Italy, United States and Netherlands. Marisa Pautasso's co-authors include Giuseppe Saglio, Daniela Cilloni, Enrico Bracco, Emanuela Messa, Sonia Carturan, Ilaria Defilippi, Francesca Arruga, Valentina Rosso, Alessandro Morotti and F. Messa and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Marisa Pautasso

33 papers receiving 574 citations

Peers

Marisa Pautasso
Marisa Pautasso
Citations per year, relative to Marisa Pautasso Marisa Pautasso (= 1×) peers Cristina Panuzzo

Countries citing papers authored by Marisa Pautasso

Since Specialization
Citations

This map shows the geographic impact of Marisa Pautasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Pautasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Pautasso more than expected).

Fields of papers citing papers by Marisa Pautasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa Pautasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Pautasso. The network helps show where Marisa Pautasso may publish in the future.

Co-authorship network of co-authors of Marisa Pautasso

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa Pautasso. A scholar is included among the top collaborators of Marisa Pautasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa Pautasso. Marisa Pautasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malentacchi, Maria, Simona Malucchi, Francesca Sperli, et al.. (2023). Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study. Neurology and Therapy. 12(4). 1375–1383. 5 indexed citations
2.
Morotti, Alessandro, Cristina Barale, Emilia Giugliano, et al.. (2023). Aberrant Platelet Aggregation as Initial Presentation of Essential Thrombocythemia: Failure of Entero-Coated Aspirin to Reduce Platelet Hyperactivation. International Journal of Molecular Sciences. 25(1). 176–176.
3.
Ferrero, Ivana, Deborah Rustichelli, Sara Castiglia, et al.. (2023). Inter-laboratory method validation of CD34+ flow-cytometry assay: the experience of Turin Metropolitan Transplant Centre.. PubMed. 34(3). 220–227. 2 indexed citations
4.
Marnetto, Fabiana, Letizia Granieri, Paola Valentino, et al.. (2014). CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study. Journal of Neuroimmunology. 277(1-2). 127–133. 5 indexed citations
5.
Pautasso, Marisa, et al.. (2012). Estudio de la función renal en pacientes con hipotiroidismo subclínico: Respuesta al tratamiento con levotiroxina. 49(3). 115–118. 1 indexed citations
6.
Coghe, Ferdinando, Germano Orrù, Matteo Erriu, et al.. (2012). C-reactive protein levels in the first days of life: a systematic statistical approach. The Journal of Maternal-Fetal & Neonatal Medicine. 25(sup5). 47–50. 1 indexed citations
7.
Borrione, Paolo, Loredana Grasso, Marisa Pautasso, et al.. (2012). Impact of Different Concentrations of Human Recombinant Growth Hormone on T Lymphocytes. International Journal of Immunopathology and Pharmacology. 25(1). 87–97. 1 indexed citations
8.
Orlando, Luca, Lisa Accomasso, Paola Circosta, et al.. (2011). TCR transfer induces TCR-mediated tonic inhibition of RAG genes in human T cells. Molecular Immunology. 48(12-13). 1369–1376. 3 indexed citations
9.
Ceppi, Paolo, Ida Rapa, Marco Lo Iacono, et al.. (2011). Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer. International Journal of Cancer. 130(8). 1777–1786. 27 indexed citations
11.
Ceppi, Paolo, Mauro Papotti, Valentina Monica, et al.. (2009). Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin. Molecular Cancer Therapeutics. 8(11). 3066–3074. 51 indexed citations
12.
Cilloni, Daniela, Cristina Panuzzo, Francesca Messa, et al.. (2008). Imatinib Induced Re-Activation of FoxO3 Transcription Factor in CML Is Responsible for the Induction of a Quiescent Status of CD34 Leukaemic Progenitor Cells.. Blood. 112(11). 1090–1090. 1 indexed citations
13.
Prolo, Paolo, Francesco Chiappelli, Alberto Angeli, et al.. (2007). Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression. Bioinformation. 1(9). 363–366. 18 indexed citations
14.
Loi, G., et al.. (2007). Unusual Clinical Presentation of Mycobacterium fortuitum Infection in an Immunocompetent Woman. Journal of Clinical Microbiology. 45(5). 1663–1665. 17 indexed citations
15.
Borrione, Paolo, Attilio Parisi, Marisa Pautasso, et al.. (2007). A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport?. PubMed. 21(3-4). 79–88. 2 indexed citations
16.
Morotti, Alessandro, Daniela Cilloni, Marisa Pautasso, et al.. (2006). NF‐kB inhibition as a strategy to enhance etoposide‐induced apoptosis in K562 cell line. American Journal of Hematology. 81(12). 938–945. 37 indexed citations
17.
Morotti, Alessandro, Daniela Cilloni, Francesca Messa, et al.. (2006). Valproate enhances imatinib‐induced growth arrest and apoptosis in chronic myeloid leukemia cells. Cancer. 106(5). 1188–1196. 30 indexed citations
18.
Cilloni, Daniela, Emanuela Messa, Alessandro Morotti, et al.. (2005). Increase in platelet count in older, poor‐risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all‐trans retinoic acid. Cancer. 104(1). 101–109. 70 indexed citations
19.
Volpe, Gisella, Barbara Gamberi, Cristina Pastore, et al.. (1996). Analysis of microsatellite instability in chronic lymphoproliferative disorders. Annals of Hematology. 72(2). 67–71. 2 indexed citations
20.
Pautasso, Marisa, et al.. (1992). Itchy dermatitis from Gynaikothrips ficorum March in a family group. Allergy. 47(4). 441–442. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026